Shell Stock Price Today: Oil Rebound and $3 Billion Adura Loan Put Shares Back in Focus

March 24, 2026
Shell Stock Price Today: Oil Rebound and $3 Billion Adura Loan Put Shares Back in Focus

LONDON, March 24, 2026, 11:52 GMT

Shell Plc’s U.S. shares edged up roughly 0.3% to $90.71 on Tuesday, tracking Brent crude’s rebound past $100 a barrel after Iran pushed back on talk of negotiations with the U.S. Investors sifted through news of a $3 billion funding deal for Adura, Shell’s North Sea partnership with Equinor. 1

This shift is significant for Shell, given its exposure on both fronts of the Gulf turmoil. Rising crude prices can boost cash flow fast. But the conflict has also hit Shell-connected assets in Qatar, while stirring up new doubts around LNG—liquefied natural gas—a business central to the group. 2

Monday was a sharp reversal. Shell dropped 4.2% in London as crude tumbled over 10% following President Donald Trump’s decision to hold off on planned cyberattacks against Iran’s power grid. By Tuesday, Tehran dismissed negotiation rumors as “fake news” and Brent snapped back, trading at $101.19 a barrel. 3

Adura’s new financing brought some definition into the picture for investors. The $3 billion, seven-year reserve-based lending facility—secured by projected oil and gas output—covers fields like Rosebank. CEO Neil McCulloch called it a source of “financial strength and flexibility” for the venture. 4

Shell’s top brass aren’t brushing aside the broader fallout. Cedric Cremers, Shell’s president of integrated gas, warned that the war threatens to undermine long-term confidence in gas supply, adding these shocks “send the wrong signals” to customers. Over on the same panel, Glencore’s energy chief Maxim Kolupaev pointed out that while current LNG volumes are enough to satisfy demand, rerouting is now essential. 2

Fallout is now creeping into upcoming projects as well. TC Energy CEO Francois Poirier pointed out that the conflict has boosted odds for a second phase at Shell’s LNG Canada export site. Shell and its partners, he said, have already prodded TC Energy to “be ready” before a decision expected later this year. 5

Peers didn’t escape the pressure either. BP dropped with Shell during Monday’s oil-driven pullback. TotalEnergies CEO Patrick Pouyanne, meanwhile, warned that a supply shock lasting over three or four months could pose a “systemic risk” to the global economy. Trade Nation’s David Morrison argued that markets haven’t factored in a closure of Hormuz—calling it a major, unexpected shift. 3

Operationally, Shell faces a tough fix. One of the trains at its Pearl GTL plant in Qatar—where gas is converted to liquid fuels—could need up to a year to get back online after the March 18 attacks. Train one came through undamaged, and there was no impact to Shell’s 30% holding in QatarEnergy LNG N(4). Details on the first quarter’s financial hit land April 8. 6

The risk isn’t one-sided. A genuine diplomatic breakthrough might send oil sliding, dragging energy shares with it. But if the Strait of Hormuz remains blocked through April, Macquarie sees Brent shooting up to $150 a barrel. Tim Waterer at KCM Trade called Tuesday’s rebound the market “finding its footing in the mud”—with Hormuz, he said, “far from a clear waterway.” 1

The shareholder-return angle hasn’t gone anywhere. Back in February, Shell stuck with its $3.5 billion quarterly buyback—despite a softer fourth-quarter profit. Over the last four years, the company has repurchased roughly a quarter of its shares, LSEG data shows. Eyes now turn to April 8, with Shell set to detail the first-quarter impact from Qatar. 7

Stock Market Today

  • EKF Diagnostics Shares React to Quarterly Results in FTSE 350
    March 24, 2026, 9:31 AM EDT. EKF Diagnostics plc (LSE:EKF), a constituent of the FTSE 350 index, saw movement in its share price following the release of its latest quarterly results. The update drew investor attention amid ongoing market volatility. EKF Diagnostics specialises in medical diagnostics, and its financial performance metrics were closely watched this quarter. Market participants reacted to the earnings report, influencing the trading volume and price fluctuations. The company's quarterly results provide insights into its operational health and future prospects in the healthcare sector, a key driver for its valuation. This movement underscores the link between earnings disclosures and market dynamics, reflecting investor sentiment towards EKF Diagnostics' business outlook.